- Home
- PHAT vs YALA Comparison
PHAT vs YALA Comparison
Compare PHAT & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- YALA
- Stock Information
- Founded
- PHAT 2018
- YALA 2016
- Country
- PHAT United States
- YALA United Arab Emirates
- Employees
- PHAT N/A
- YALA N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- YALA Computer Software: Programming Data Processing
- Sector
- PHAT Health Care
- YALA Technology
- Exchange
- PHAT Nasdaq
- YALA Nasdaq
- Market Cap
- PHAT 539.5M
- YALA 645.8M
- IPO Year
- PHAT 2019
- YALA 2020
- Fundamental
- Price
- PHAT $8.32
- YALA $4.30
- Analyst Decision
- PHAT Strong Buy
- YALA
- Analyst Count
- PHAT 4
- YALA 0
- Target Price
- PHAT $23.00
- YALA N/A
- AVG Volume (30 Days)
- PHAT 992.3K
- YALA 350.9K
- Earning Date
- PHAT 11-07-2024
- YALA 11-11-2024
- Dividend Yield
- PHAT N/A
- YALA N/A
- EPS Growth
- PHAT N/A
- YALA 31.83
- EPS
- PHAT N/A
- YALA 0.74
- Revenue
- PHAT $26,270,000.00
- YALA $329,773,319.00
- Revenue This Year
- PHAT $7,622.43
- YALA $6.23
- Revenue Next Year
- PHAT $236.87
- YALA $11.04
- P/E Ratio
- PHAT N/A
- YALA $5.93
- Revenue Growth
- PHAT N/A
- YALA 5.34
- 52 Week Low
- PHAT $6.07
- YALA $3.71
- 52 Week High
- PHAT $19.71
- YALA $6.31
- Technical
- Relative Strength Index (RSI)
- PHAT 36.67
- YALA 51.64
- Support Level
- PHAT $7.81
- YALA $4.33
- Resistance Level
- PHAT $8.56
- YALA $4.50
- Average True Range (ATR)
- PHAT 0.59
- YALA 0.14
- MACD
- PHAT 0.22
- YALA 0.00
- Stochastic Oscillator
- PHAT 38.28
- YALA 56.58
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.